Low day 100 transplant-related mortality (TRM) and relapse rate following clofarabine (CLO) in combination with cytarabine, total body irradiation (TBI), and allogeneic stem cell transplantation (AlloSCT) in children, adolescents, and young adults (CAYA) with poor-risk acute leukemia.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: New York Medical College, Columbia University, Harvard University, Massachusetts General Hospital, University of Louisville, Medical College of Wisconsin, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Hackensack University Medical Center, University of Hawaiʻi at Mānoa, University of Hawaii System, University of California, San Francisco
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2596611191
